Ro 40-7592, a COMT inhibitor, plus levodopa in Parkinson's disease

Lancet. 1993 Jun 19;341(8860):1605. doi: 10.1016/0140-6736(93)90750-b.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Benzophenones / pharmacokinetics
  • Benzophenones / therapeutic use*
  • Catechol O-Methyltransferase Inhibitors*
  • Double-Blind Method
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Humans
  • Levodopa / pharmacokinetics
  • Levodopa / therapeutic use*
  • Male
  • Nitrophenols
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Tolcapone

Substances

  • Benzophenones
  • Catechol O-Methyltransferase Inhibitors
  • Nitrophenols
  • Levodopa
  • Tolcapone